Advancing the neuroelectrophysiological understanding of attentional switching dysfunction in major depressive disorder

Table 1 Summary of evidence for emotional interference in attentional switching in major depressive disorder

Aspect of interference	Behavioral evidence	ERP/neurophysiological evidence	Theoretical interpretation
Engagement/attention capture by negative stimuli	Slower response times on trials following negative stimuli; difficulty ignoring negative distractors	Enhanced early components (P1, N170) and/or reduced P200 to negative vs neutral/positive stimuli	Hyper-vigilance or facilitated early orientation towards threat/mood-congruent information
Disengagement difficulty from negative stimuli	Increased response time cost when shifting attention away from a negative cue/location	Prolonged late positivity (LPP) or sustained frontal negativity for negative stimuli; reduced P300 for subsequent targets	Impaired top-down control to terminate processing of negative information, leading to “sticky” attention
Impaired switching in negative context	Poorer accuracy and slower switching specifically when negative material is involved	Reduced P300 and LPP amplitudes on switch trials with emotional vs. neutral stimuli; altered fronto-central theta synchronization	Negative emotion consumes/degrades executive resources needed for set-shifting and task reconfiguration
Blunted processing of positive stimuli	Reduced facilitation from positive cues; diminished reward learning	Attenuated LPP and RewP to positive/rewarding stimuli	Anhedonia and reduced motivational salience of positive information, failing to provide a protective or facilitative effect on switching

ERP: Event-related potential; LPP: Late positive potential; RewP: Reward positivity.

Table 2 Key event-related potential components implicated in attentional and emotional processing dysfunction in major depressive disorder

ERP component	Typical latency	Functional/cognitive significance	Typical finding in MDD	Postulated implication in attentional switching
P100/N170	80-170 ms	Early sensory processing/structural encoding of faces.	Often intact or even enhanced for emotional faces	Suggests basic perceptual encoding is not the primary deficit. May feed heightened signal to later stages
P200	150-250 ms	Early attentional engagement, initial stimulus evaluation, and categorization	Reduced amplitude, especially for negative emotional stimuli	Indicates impaired early filtering and resource allocation to task-relevant or emotional features during a switch
N200	200-350 ms	Conflict monitoring, response inhibition	Findings mixed; may be enhanced in contexts of high conflict	Could relate to increased conflict detection during switching, especially when inhibiting a pre-potent response
P300	300-500 ms	Context updating, attention allocation, and memory processing	Robustly reduced amplitude across many paradigms	Reflects broader deficits in updating mental representations and allocating resources after a task switch
LPP	400-1000 ms	Sustained attention, elaborative processing, and motivational significance of stimuli	Reduced amplitude, particularly for positive and sometimes negative stimuli	Indicates failure to maintain focused cognitive resources on task-relevant or emotional information over time
ERN	50-100 ms	Early, automatic error detection	Often enhanced amplitude	Suggests hyper-vigilant performance monitoring, which may be maladaptive and contribute to rumination

ERN: Error-related negativity; ms: Millisecond; ERP: Event-related potential; MDD: Major depressive disorder; LPP: Late positive potential.

Table 3 Methodological paradigms for studying attentional switching in major depressive disorder: Advantages and event-related potential correlates

Paradigm	Core cognitive demand	Key attentional process probed	Primary ERP components of interest	Strengths for MDD research
Task-switching	Shift between different task rules (e.g., classify by color vs shape)	Cognitive flexibility, set reconfiguration, rule updating	SP, P300	Isolates “pure” executive switching, minimal emotional confound
Dual-task (as in Wu et al[9])	Perform two concurrent, alternating tasks	Divided attention, rapid resource sharing, interference management	N100, P200, P300, LPP across task transitions	High ecological validity, tests ability under load resembling daily life
Emotional variant of switching	Switch attention based on emotional vs non-emotional features	Interaction between affective processing and cognitive control	N170, P200, LPP; modulation of switch-related components by emotion	Directly tests the emotion-cognition interaction deficit central to MDD
Attentional blink with emotional stimuli	Identify targets in a rapid stream; emotional distractors are inserted	Temporal attention, vulnerability to emotional disruption	P3 to targets, attenuation of P3 by emotional distractors	Probes how emotion disrupts the attentional “gate” over time
Cue-target with emotional primes	Respond to a target preceded by an emotional or neutral cue	Attentional orienting and disengagement	Cue-locked LPP, target-locked P1/N1, P300	Dissociates the stages of attention: Engagement with cue vs. disengagement to target

ERP: Event-related potential; MDD: Major depressive disorder; LPP: Late positive potential; SP: Switch-related positivity.

Table 4 Potential clinical translation pathways for event-related potential biomarkers in major depressive disorder

Clinical application	Description	Example ERP biomarker	Current evidence stage	Challenges
Diagnostic Aid/subtyping	Objective measure to support clinical diagnosis or define cognitively distinct subgroups	Reduced P300 amplitude; blunted LPP to rewards	Promising research evidence; requires large normative databases and defined cut-offs	High inter-individual variability; overlap with other disorders
Predictor of treatment response	Baseline ERP profile predicting likelihood of response to a specific therapy (e.g., CBT, antidepressants)	Pre-treatment RewP or frontal theta activity	Early experimental stage; several promising candidate markers	Need for large, prospective, treatment-specific studies
Monitor of treatment process	ERP changes during treatment signaling engagement of target neural mechanisms	Increase in P300/LPP to positive stimuli during ABM or antidepressant treatment	Conceptually strong; used in mechanistic research studies	Establishing causal links between neural change and clinical outcome
Target for neuromodulation	Using aberrant ERP activity (source-localized) to guide brain stimulation targets	Reduced frontal P300 mapped to DLPFC for rTMS targeting	Experimental; used in some research protocols	Requires combined EEG-source imaging and neuromodulation
Index of functional recovery	ERP normalization associated with recovery of real-world cognitive/occupational function	Correlation between P300 amplitude recovery and return-to-work measures	Longitudinal studies are beginning to explore this	Long timeframes and multifactorial nature of functional outcomes

ERP: Event-related potential; LPP: Late positive potential; RewP: Reward positivity; CBT: Cognitive behavioral therapy; Aid: Assistance in depression; DLPFC: Dorsolateral prefrontal cortex; ABM: Attention bias modification; rTMS: Repetitive transcranial magnetic stimulation; EEG: Electroencephalography.

Table 5 Key future research directions to advance the field

Research direction	Core scientific question	Recommended methodological approach	Expected outcome/impact
Longitudinal trajectories	Do ERP abnormalities precede, coincide with, or follow depressive episodes? Are they normalized by treatment	Prospective studies of high-risk cohorts; treatment trials with ERP assessments at multiple timepoints	Determine causal role and clinical utility as predictive/prognostic biomarkers
Circuit mechanisms	Which specific large-scale brain networks show dysfunctional communication during attentional switching	Simultaneous EEG-fMRI; source-localized EEG connectivity analysis during switching tasks	Identify novel neurobiological targets for brain stimulation or circuit-based therapeutics
Personalized prediction	Can a combination of ERP, clinical, and genomic data predict individual treatment outcomes	Machine learning on multimodal datasets from large clinical trials	Move towards personalized medicine in psychiatry
Real-world translation	How do lab-measured ERP deficits manifest in daily life attention and functioning	Studies pairing lab-based EEG with EMA of cognition in daily life	Validate the ecological significance of ERP biomarkers and link them to patient-centered outcomes
Developmental perspective	How do attentional switching circuits and their dysfunction evolve from adolescence to late-life depression	Cross-sectional and longitudinal studies across the lifespan	Identify optimal windows for early intervention and age-specific treatment targets

ERP: Event-related potential; EEG: Electroencephalography; fMRI: Functional magnetic resonance imaging; EMA: Ecological momentary assessment.